New investigations have placed The Company under intense scrutiny concerning its drug development and marketing practices. Concerns regarding seemingly questionable research methods and pushy promotion approaches have ignited extensive alarm among regulators, investors, and public rights organizations. The situation is prompting a complete evaluat